Progression of steroid-associated osteoporosis after heart transplantation  Jochen Cremer, MD, Martin Strüber, MD, Ingrid Wagenbreth, MD, Johannes Nischelsky,

Slides:



Advertisements
Similar presentations
Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Advertisements

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Manuel J. Antunes, MD, PhD, DSc 
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
What Predicts Long-Term Survival After Heart Transplantation
Keith B Allen, MD, Carl J Shaar, PhD  The Annals of Thoracic Surgery 
The STS National Database
Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure  Klaus Pethig, MD, Andrea Milz, Christian Hagl, MD, Wolfgang.
Treatment of a persistent postoperative chylothorax with somatostatin
Heart–lung transplantation in a patient with large aortopulmonary collaterals by means of an extended approach  Klaus Kallenbach, MD, Andre R. Simon,
Thomas V Bilfinger, MD, George B Stefano, PhD 
Peter K. Smith, MD, Michel Carrier, MD, John C
James A Haugen, MBA, George E Miller, MD 
Alternative Technique of the Right Atrial Anastomosis (Cavo-Atrial) in Orthotopic Heart Transplantation  Sandra Fraund, MD, Aziz Rahimi, MD, Stefan Hirt,
CTSNet: a unique educational vehicle
Progression of steroid-associated osteoporosis after heart transplantation  Jochen Cremer, MD, Martin Strüber, MD, Ingrid Wagenbreth, MD, Johannes Nischelsky,
Mini-sternotomy for off-pump coronary artery bypass grafting
Less Is More in Post Pediatric Heart Transplant Care
What is the marginal cost for marginal risk in cardiac surgery?
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
The CarboMedics “Top-Hat” supraannular prosthesis
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation  Steven A. Farmer, MD, PhD, Kathleen L. Grady,
Pleural Metastasis of Osteosarcoma
Public policy and the practicing physician
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Percutaneous Tissue-Engineered Pulmonary Valved Stent Implantation
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass  Martin Strüber, MD, Jochen T Cremer, MD, Bernhard.
Origins of the Cardiothoracic Surgery Network (CTSNet)
Videothoracoscopic Treatment of Hepatic Hydrothorax
Who Do You Say You Are? The Annals of Thoracic Surgery
Ventricular assist device programs: design and function
Palmar Microcirculation After Harvesting of the Radial Artery in Coronary Revascularization  Karsten Knobloch, MD, Artur Lichtenberg, MD, Max Pichlmaier,
Use of Amiodarone After Major Lung Resection
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Progressive Tracheal Erosion Consecutive to a Calcified Left Thyroid Lobe  Anne B. Olland, MD, MS, Pierre-Emmanuel Falcoz, MD, PhD, Nicola Santelmo, MD,
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Are older patients with mechanical heart valves at increased risk?
Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L
Hybrid Management of a Giant Left Main Coronary Artery Aneurysm
A first start for lung transplantation?
Anastasios K. Konstantakos, MD, R. Thomas Temes, MD 
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Complementary Alternative Medical Therapies for Heart Surgery Patients: Feasibility, Safety, and Impact  Vibhu R. Kshettry, MD, Linda Flies Carole, PsyD,
Editorial Board, January 2010
Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD 
C1-esterase inhibitor reduces reperfusion injury after lung transplantation  Mirela Scherer, MD, Stefanos Demertzis, MD, PhD, Frank Langer, MD, Anton Moritz,
The Ross procedure: Time to reevaluate the guidelines
Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement  Ulrich Franke, MD, Thorsten Wahlers, MD, Tina.
Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds
Late Postpneumonectomy Death From Stump Thrombus
Adenocarcinoma in a mid-esophageal diverticulum
A new minimally invasive approach to the subclavian artery
Contraceptive Implant Embolism Into the Pulmonary Artery: Thoracoscopic Retrieval  Pascal A. Thomas, MD, PhD, Donatella Di Stefano, MD, Cécile Couteau,
Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer  Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Heidi Goerler, MD, Andre Simon, MD, Gregor Warnecke, MD, Anna L
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
A Close Call: An Impacted Knife Injury to the Thorax
Should heart transplantation be considered as a treatment option for patients aged 70 years and older?  Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.
Adnan Cobanoglu, MD, Jess M Schultz, MD  The Annals of Thoracic Surgery 
Late Consequences of a Much Earlier Decision
Removal of an intrathoracic migrated fixation pin by thoracoscopy
The Impact of New Technology on Cardiothoracic Surgical Practice
Antero-axillary access for hypoplastic aortic arch repair
Heart transplantation: echocardiographic assessment of morphology and function after more than 10 years of follow-up  Michaela Wilhelmi, MD, Klaus Pethig,
Heart Transplant Program Volume Is Not a Measure of Quality
The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi  Edimar Alcides Bocchi, MD, Alfredo Fiorelli,
J. Alberto Lopez, MD  The Annals of Thoracic Surgery 
Surgical Experience in a Patient With Loeys-Dietz Syndrome Type I
Presentation transcript:

Progression of steroid-associated osteoporosis after heart transplantation  Jochen Cremer, MD, Martin Strüber, MD, Ingrid Wagenbreth, MD, Johannes Nischelsky, MD, Stefanos Demertzis, MD, Thomas Graeter, MD, Conny Abraham, PhD, Axel Haverich, MD  The Annals of Thoracic Surgery  Volume 67, Issue 1, Pages 130-133 (January 1999) DOI: 10.1016/S0003-4975(98)01040-6

Fig 1 Maintenance steroid dose (prednisone) after 1, 3, 6, 9, and 12 months in each group. The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)

Fig 2 Course of trabecular bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)

Fig 3 Course of cortical bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)

Fig 4 Course of trabecular bone density (mean of T12, L1, L2, and L3) in men older or younger than 40 years independent of elcitonin treatment. (∗p < 0.05.) The Annals of Thoracic Surgery 1999 67, 130-133DOI: (10.1016/S0003-4975(98)01040-6)